» Articles » PMID: 36130813

Response To: "Updated and Rectified Meta-analysis Shows No Effect of Propranolol Versus Placebo on Traumatic Memory Reconsolidation Disruption"

Overview
Specialty Psychiatry
Date 2022 Sep 21
PMID 36130813
Authors
Affiliations
Soon will be listed here.
References
1.
Gisquet-Verrier P, Le Dorze C . Post Traumatic Stress Disorder and Substance Use Disorder as Two Pathologies Affecting Memory Reactivation: Implications for New Therapeutic Approaches. Front Behav Neurosci. 2019; 13:26. PMC: 6381044. DOI: 10.3389/fnbeh.2019.00026. View

2.
Schmucker C, Blumle A, Schell L, Schwarzer G, Oeller P, Cabrera L . Systematic review finds that study data not published in full text articles have unclear impact on meta-analyses results in medical research. PLoS One. 2017; 12(4):e0176210. PMC: 5404772. DOI: 10.1371/journal.pone.0176210. View

3.
Pachas G, Gilman J, Orr S, Hoeppner B, Carlini S, Grasser E . Single dose propranolol does not affect physiologic or emotional reactivity to smoking cues. Psychopharmacology (Berl). 2014; 232(9):1619-28. PMC: 4404704. DOI: 10.1007/s00213-014-3797-6. View

4.
Brunet A, Saumier D, Liu A, Streiner D, Tremblay J, Pitman R . Reduction of PTSD Symptoms With Pre-Reactivation Propranolol Therapy: A Randomized Controlled Trial. Am J Psychiatry. 2018; 175(5):427-433. DOI: 10.1176/appi.ajp.2017.17050481. View

5.
Steenen S, Su N, van Westrhenen R, van Wijk A, Tjia D, de Lange J . Perioperative Propranolol Against Dental Anxiety: A Randomized Controlled Trial. Front Psychiatry. 2022; 13:842353. PMC: 8899208. DOI: 10.3389/fpsyt.2022.842353. View